Skip to main content Deutsch

News

MedUni Vienna gains access to an international platform for the development of fully human antibodies

University, Medicine & Science

Partnership grants Ignaz Semmelweis Institute access to Nona’s H2L2 Harbour Mice transgenic mouse technology platform for translational antibody…

Genetic basis of susceptibility to circadian rhythm disruption investigated

Medicine & Science

Study reveals the interplay of genetic factors in circadian imbalance

New approach to the development of non-opioid painkillers

Medicine & Science

Peptide derived from cone snail venom alleviates inflammation-related pain in an animal model

Study highlights the particular importance of science communication for risk perception

Medicine & Science

Online survey by the LBI SOAP following a hantavirus outbreak on a cruise ship

 

New approach to personalised therapy following kidney transplantation

Medicine & Science

Study provides initial evidence of the potential of a blood-based biomarker in rejection reactions

 

Supportive measures are crucial in drug-based obesity treatment

Medicine & Science

Comprehensive recommendations on support for incretin-based obesity therapies published for the first time

WE&ME Award: Unravelling biological differences in ME/CFS

Medicine & Science

Research grant for Matthias Wielscher – FWF funding also awarded to Lilian Konicar

Nicole Concin and Igor Grabovac elected to the Oncology Advisory Board

Medicine & Science, People of the MedUni Vienna

The Ministry of Health’s advisory board comprises experts in cancer care in Austria

MedUni Vienna spin-off FOOLPROOF SKIN named “Rising Star of the Year”

University, Medicine & Science

Award at the EY Scale-up Award 2026 for data-driven app offering personalised skin and hair analysis